Hormone Refractory Prostate Cancer Market Report

Global and Region Hormone Refractory Prostate Cancer Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：166
  • REPORT CODE：GMM885798
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hormone Refractory Prostate Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hormone Refractory Prostate Cancermarket, defines the market attractiveness level of Hormone Refractory Prostate Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hormone Refractory Prostate Cancer industry, describes the types of Hormone Refractory Prostate Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hormone Refractory Prostate Cancer market and the development prospects and opportunities of Hormone Refractory Prostate Cancer industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hormone Refractory Prostate Cancer market in Chapter 13.

    By Player:

    • Astellas Inc

    • Sanofi SA

    • Dendreon Corporation, Bayer AG

    • Johnson & Johnson

    By Type:

    • Chemotherapy

    • Hormonal Therapy

    • Immunotherapy

    • Radiation Therapy

    • Surgery

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Specialty Clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hormone Refractory Prostate Cancer Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hormone Refractory Prostate Cancer Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hormone Refractory Prostate Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hormone Refractory Prostate Cancer Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hormone Refractory Prostate Cancer Market Analysis and Outlook to 2022

    • 7.1 Global Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.2 United States Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.3 Europe Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.4 China Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.5 Japan Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.6 India Hormone Refractory Prostate Cancer Consumption (2017-2022)

    • 7.7 South Korea Hormone Refractory Prostate Cancer Consumption (2017-2022)

    8 Region and Country-wise Hormone Refractory Prostate Cancer Market Analysis and Outlook to 2028

    • 8.1 Global Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.2 United States Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.3 Europe Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.4 China Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.5 Japan Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.6 India Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    • 8.7 South Korea Hormone Refractory Prostate Cancer Consumption Forecast (2022-2028)

    9 Global Hormone Refractory Prostate Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Hormone Refractory Prostate Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Surgery Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hormone Refractory Prostate Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    10 Global Hormone Refractory Prostate Cancer Market Outlook by Types and Applications to 2028

    • 10.1 Global Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hormone Refractory Prostate Cancer Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hormone Refractory Prostate Cancer Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hormone Refractory Prostate Cancer Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hormone Refractory Prostate Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hormone Refractory Prostate Cancer Market Competitive Analysis

    • 14.1 Astellas Inc

      • 14.1.1 Astellas Inc Company Details

      • 14.1.2 Astellas Inc Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Inc Hormone Refractory Prostate Cancer Product and Service

    • 14.2 Sanofi SA

      • 14.2.1 Sanofi SA Company Details

      • 14.2.2 Sanofi SA Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi SA Hormone Refractory Prostate Cancer Product and Service

    • 14.3 Dendreon Corporation, Bayer AG

      • 14.3.1 Dendreon Corporation, Bayer AG Company Details

      • 14.3.2 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hormone Refractory Prostate Cancer

    • Figure Hormone Refractory Prostate Cancer Picture

    • Table Global Hormone Refractory Prostate Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hormone Refractory Prostate Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hormone Refractory Prostate Cancer Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hormone Refractory Prostate Cancer Consumption by Country (2017-2022)

    • Figure United States Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure China Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hormone Refractory Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Refractory Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hormone Refractory Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hormone Refractory Prostate Cancer Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hormone Refractory Prostate Cancer Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Inc Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Inc Hormone Refractory Prostate Cancer Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Hormone Refractory Prostate Cancer Product and Service

    • Table Dendreon Corporation, Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Hormone Refractory Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Hormone Refractory Prostate Cancer Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US